Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Investigational drugs under development for the treatment of PTSD.

Expert opinion on investigational drugs - 1 May 2015

Ragen Benjamin J, Seidel Jordan, Chollak Christine, Pietrzak Robert H, Neumeister Alexander

Abstract excerpt

INTRODUCTION: Posttraumatic stress disorder (PTSD) is a prevalent, chronic and disabling anxiety disorder that may develop following exposure to a traumatic event. There is currently no effective pharmacotherapy for PTSD and therefore the discovery of novel, evidence-based treatments is particularly important. This review of potential novel treatments could act as a catalyst for further drug investigation. AREAS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Stress Disorders, Post-Traumatic
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drugs, Investigational

Share to Evidence-Based Medicine

Share to Molecular Targeted Therapy

Share to Phenotype

Share to Precision Medicine

Source

Identifiers

PMID: 25773140
DOI: 10.1517/13543784.2015.1020109

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Investigational drugs under development for the treatment of PTSD.PMID 25773140Read ↗

To Predict, Prevent, and Manage Post-Traumatic Stress Disorder (PTSD): A Review of Pathophysiology, Treatment, and Biomarkers.Semantic proximity Read ↗

Advancement of a valid model of chronic PTSD and repetitive mTBI : implications for pathophysiology and drug discoverySemantic proximity Read ↗

Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSDSemantic proximity Read ↗

Pharmacogenetics and Pharmacotherapy of Military Personnel Suffering from Post-traumatic Stress Disorder.Semantic proximity Read ↗

Review of somatic symptoms in post-traumatic stress disorderSemantic proximity Read ↗

Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder.Semantic proximity Read ↗

Pharmahuasca Reduces ROS Production and inflammatory Gene Expression in the Brain in a Model of PTSD: Exploration by RNA SequencingSemantic proximity Read ↗

Animal models in translational studies of PTSD.Semantic proximity Read ↗

Critical Analysis of Classical and Novel Risk Factors to Post-traumatic Stress Disorders in military populations.Semantic proximity Read ↗

MDMA-Assisted Therapy Randomized Controlled Trial Incremental Effects Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Sex Differences in Endocannabinoid and Inflammatory Markers Associated with Posttraumatic Stress DisorderSemantic proximity Read ↗

Current Status of Animal Models of Posttraumatic Stress Disorder: Behavioral and Biological Phenotypes, and Future Challenges in Improving Translation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.